Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Cytopplex Forte
- Development stage
- Unknown
- Lead developer
- Anglo-French Drugs & Industries
- Modality
- Small Molecules
- Administration
- Oral
01
Overview
Cytopplex Forte (also marketed as Cytoplex Forte) is an oral B-complex vitamin supplement formulated with biotin and vitamin C. Developed by Anglo-French Drugs & Industries, it is designed to address vitamin B deficiencies, fatigue, weakness, muscle pain, and general nutritional deficiencies. Each tablet contains a therapeutic blend of B vitamins (thiamine, riboflavin, nicotinic acid, niacinamide, calcium pantothenate, pyridoxine, folic acid, and cyanocobalamin) along with ascorbic acid (vitamin C) and biotin to support cellular energy production, immune function, and the maintenance of healthy skin, hair, and nails.
- Brand names
- Cytoplex ForteCytopplex Forte
Beyond the preview
Go deeper on Cytopplex Forte.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Cytopplex Forte.